Compare company and executive activity with congressional disclosures. Coinciding events do not establish coordination or wrongdoing.
Loading SEC filings and reported buybacks…
Open-market or private purchases of non-derivative securities reported by officers and directors (code P). Grants, option exercises, and sales are excluded. These are personal transactions, not company buybacks.
Director · Common Stock
Transaction: 2026-09-16
Filed: 2026-09-17
Director · Common Stock
Transaction: 2026-09-14
Filed: 2026-09-15
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Director · Common Stock
Transaction: 2026-09-14
Filed: 2026-09-15
Free includes up to 3 qualifying purchases from the latest 20 ownership filings and the latest reported buyback period. Plus unlocks older available filing pages and reported buyback history.
Compare plansReported cash payments to repurchase common stock, in US dollars. Periods can overlap and include year-to-date totals; do not add these rows together. These are reported payments, not announcement amounts or daily trades.
| Reporting period | Cash paid (USD) | Filed | Source |
|---|---|---|---|
| 2025-11-01 – 2026-07-31 | $447,200,000.00 | 2026-09-09 | 10-Q ↗ |
Latest available standardized authorization fact: 2017-03-31. Filed 2024-03-01.
This may be an old or cumulative program amount. It is not a new announcement, remaining capacity, or a commitment to purchase shares.
Read the program terms in the filing ↗